While these are chosen through rigorous experimental validation as transcripts that are stable under the experimental conditions of interest, they might still be affected in other situations; for example, beta-2-microglobulin is altered in neurological and psychiatric conditions, such as multiple sclerosis and schizophrenia [64, 65]. This evidence concerns the gene B2M and schizophrenia.